Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 345305, 9 pages
http://dx.doi.org/10.1155/2014/345305
Research Article

Simultaneous Changes of Spatial Memory and Spine Density after Intrahippocampal Administration of Fibrillar Aβ1–42 to the Rat Brain

Department of Medical Chemistry, University of Szeged, Dóm tér 8, Szeged 6720, Hungary

Received 16 March 2014; Revised 25 May 2014; Accepted 2 June 2014; Published 23 June 2014

Academic Editor: Raymond Chuen-Chung Chang

Copyright © 2014 Emőke Borbély et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Terry, E. Masliah, D. P. Salmon et al., “Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment,” Annals of Neurology, vol. 30, no. 4, pp. 572–580, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Allan Butterfield, A. Castegna, C. M. Lauderback, and J. Drake, “Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death,” Neurobiology of Aging, vol. 23, no. 5, pp. 655–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Kar, S. P. M. Slowikowski, D. Westaway, and H. T. J. Mount, “Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease,” Journal of Psychiatry and Neuroscience, vol. 29, no. 6, pp. 427–441, 2004. View at Google Scholar · View at Scopus
  4. F.-Q. He, B.-Y. Qiu, X.-H. Zhang et al., “Tetrandrine attenuates spatial memory impairment and hippocampal neuroinflammation via inhibiting NF-κB activation in a rat model of Alzheimer's disease induced by amyloid-β1-42,” Brain Research, vol. 1384, pp. 89–96, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. B. M. Pause, A. Zlomuzica, K. Kinugawa, J. Mariani, R. Pietrowsky, and E. Dere, “Perspectives on episodic-like and episodic memory,” Frontiers in Behavioral Neuroscience, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Braak and E. Braak, “Neuropathological stageing of Alzheimer-related changes,” Acta Neuropathologica, vol. 82, no. 4, pp. 239–259, 1991. View at Google Scholar · View at Scopus
  7. D. A. Butterfield, M. Perluigi, and R. Sultana, “Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics,” European Journal of Pharmacology, vol. 545, no. 1, pp. 39–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. J. Baloyannis, “Dendritic pathology in Alzheimer's disease,” Journal of the Neurological Sciences, vol. 283, no. 1-2, pp. 153–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Selkoe, “Translating cell biology into therapeutic advances in Alzheimer's disease,” Nature, vol. 399, no. 6738, supplement, pp. A23–A31, 1999. View at Google Scholar · View at Scopus
  10. D. J. Selkoe, “Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein,” Journal of Alzheimer's Disease, vol. 3, no. 1, pp. 75–81, 2001. View at Google Scholar · View at Scopus
  11. M. P. Mattson, “Pathways towards and away from Alzheimer's disease,” Nature, vol. 430, no. 7000, pp. 631–639, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Chabrier, D. Cheng, N. A. Castello, K. N. Green, and F. M. Laferla, “Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease,” Neurobiology of Disease, vol. 64, pp. 107–117, 2014. View at Google Scholar
  13. J. Tsai, J. Grutzendler, K. Duff, and W.-B. Gan, “Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches,” Nature Neuroscience, vol. 7, no. 11, pp. 1181–1183, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Knafo, L. Alonso-Nanclares, J. Gonzalez-Soriano et al., “Widespread changes in dendritic spines in a model of Alzheimer's Disease,” Cerebral Cortex, vol. 19, no. 3, pp. 586–592, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. M. Koffie, M. Meyer-Luehmann, T. Hashimoto et al., “Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 10, pp. 4012–4017, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. F. M. LaFerla, K. N. Green, and S. Oddo, “Intracellular amyloid-β in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 8, no. 7, pp. 499–509, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. E. A. Nimchinsky, B. L. Sabatini, and K. Svoboda, “Structure and function of dendritic spines,” Annual Review of Physiology, vol. 64, pp. 313–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. V. A. Alvarez and B. L. Sabatini, “Anatomical and physiological plasticity of dendritic spines,” Annual Review of Neuroscience, vol. 30, pp. 79–97, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. D. L. Smith, J. Pozueta, B. Gong, O. Arancio, and M. Shelanski, “Reversal of long-term dendritic spine alterations in Alzheimer disease models,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 39, pp. 16877–16882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Jain, S. Y. Yoon, L. Leung, J. Knoferle, and Y. Huang, “Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development,” PLoS ONE, vol. 8, no. 3, Article ID e59478, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Morrison and M. G. Baxter, “The ageing cortical synapse: Hallmarks and implications for cognitive decline,” Nature Reviews Neuroscience, vol. 13, no. 4, pp. 240–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. J. I. Luebke, C. M. Weaver, A. B. Rocher et al., “Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models,” Brain Structure and Function, vol. 214, no. 2-3, pp. 181–199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. H. Bhatt, S. Zhang, and W.-B. Gan, “Dendritic spine dynamics,” Annual Review of Physiology, vol. 71, pp. 261–282, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Matsuzaki, N. Honkura, G. C. R. Ellis-Davies, and H. Kasai, “Structural basis of long-term potentiation in single dendritic spines,” Nature, vol. 429, no. 6993, pp. 761–766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wan, X. Hu, J. Nie et al., “Effects of triptolide on degeneration of dendritic spines induced by Aβ1-40 injection in rat hippocampus,” Neurological Sciences, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. A. Chacón, M. I. Barría, C. Soto, and N. C. Inestrosa, “β-sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits,” Molecular Psychiatry, vol. 9, no. 10, pp. 953–961, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S.-Z. Zhong, Q.-H. Ge, Q. Li, R. Qu, and S.-P. Ma, “Peoniflorin attentuates Aβ1-42-mediated neurotoxicity by regulating calcium homeostasis and ameliorating oxidative stress in hippocampus of rats,” Journal of the Neurological Sciences, vol. 280, no. 1-2, pp. 71–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Gong, X. Lu, L. Zhan et al., “Role of the SNK-SPAR pathway in the development of Alzheimer's disease,” IUBMB Life, vol. 62, no. 3, pp. 214–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Li, G. Wang, J. Liu et al., “Puerarin attenuates amyloid-beta-induced cognitive impairment through suppression of apoptosis in rat hippocampus in vivo,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 195–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. G. Choi, M. Moon, H. G. Kim et al., “Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ1-42 oligomer injection,” Neurobiology of Learning and Memory, vol. 96, no. 2, pp. 306–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Jantaratnotai, J. K. Ryu, C. Schwab, P. L. McGeer, and J. G. McLarnon, “Comparison of vascular perturbations in an Aβ-injected animal model and in AD brain,” International Journal of Alzheimer's Disease, vol. 2011, Article ID 918280, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Quan, J. Wang, X. Li, and Y. Wang, “Ginsenoside Rg1 decreases Aβ1-42 level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease,” PLoS ONE, vol. 8, no. 3, Article ID e59155, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. P. He, X. Ouyang, S. Zhou et al., “A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease,” Hormones and Behavior, vol. 64, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. X.-J. Liu, L. Yuan, D. Yang et al., “Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats,” Synapse, vol. 67, no. 9, pp. 626–636, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Zheng, J. Liu, Z. Ruan et al., “Intrahippocampal injection of Aβ1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain,” Amyloid, vol. 20, no. 1, pp. 13–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Jia, L. Kang, S. Li et al., “Amelioratory effects of testosterone treatment on cognitive performance deficits induced by soluble Abeta1-42 oligomers injected into the hippocampus,” Hormones and Behavior, vol. 64, no. 3, pp. 477–486, 2013. View at Google Scholar
  37. Y. Yin, Y. Ren, W. Wu et al., “Protective effects of bilobalide on Aβ25-35 induced learning and memory impairments in male rats,” Pharmacology Biochemistry and Behavior, vol. 106, pp. 77–84, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Zhang, Y.-F. Zhena, L.-G. Song et al., “Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus,” Behavioural Brain Research, vol. 244, pp. 70–81, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. G. M. Bishop and S. R. Robinson, “The amyloid hypothesis: let sleeping dogmas lie?” Neurobiology of Aging, vol. 23, no. 6, pp. 1101–1105, 2002. View at Google Scholar · View at Scopus
  40. W. Wei, L. N. Nguyen, H. W. Kessels, H. Hagiwara, S. Sisodia, and R. Malinow, “Amyloid beta from axons and dendrites reduces local spine number and plasticity,” Nature Neuroscience, vol. 13, no. 2, pp. 190–196, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. P. K.-Y. Chang, S. Boridy, R. A. McKinney, and D. Maysinger, “Letrozole potentiates mitochondrial and dendritic spine impairments induced by β amyloid,” Journal of Aging Research, vol. 2013, Article ID 538979, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Meng, Z. He, and D. Xing, “Low-level laser therapy rescues dendrite atrophy via upregulating BDNF expression: implications for Alzheimer's disease,” Journal of Neuroscience, vol. 33, no. 33, pp. 13505–13517, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Nath, L. Agholme, F. R. Kurudenkandy, B. Granseth, J. Marcusson, and M. Hallbeck, “Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid,” Journal of Neuroscience, vol. 32, no. 26, pp. 8767–8777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Leuner, S. Mendolia-Loffredo, Y. Kozorovitskiy, D. Samburg, E. Gould, and T. J. Shors, “Learning enhances the survival of new neurons beyond the time when the hippocampus is required for memory,” Journal of Neuroscience, vol. 24, no. 34, pp. 7477–7481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Leuner and T. J. Shors, “New spines, new memories,” Molecular Neurobiology, vol. 29, no. 2, pp. 117–130, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Bozso, B. Penke, D. Simon et al., “Controlled in situ preparation of Aβ1-42 oligomers from the isopeptide “iso-Aβ1-42”, physicochemical and biological characterization,” Peptides, vol. 31, no. 2, pp. 248–256, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, London, UK, 1982.
  48. D. Nagy, K. Kocsis, J. Fuzik et al., “Kainate postconditioning restores LTP in ischemic hippocampal CA1: onset-dependent second pathophysiological stress,” Neuropharmacology, vol. 61, no. 5-6, pp. 1026–1032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. D. J. Selkoe, “Alzheimer's disease is a synaptic failure,” Science, vol. 298, no. 5594, pp. 789–791, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. P. N. Lacor, M. C. Buniel, L. Chang et al., “Synaptic targeting by Alzheimer's-related amyloid β oligomers,” Journal of Neuroscience, vol. 24, no. 45, pp. 10191–10200, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. P. N. Lacor, M. C. Buniel, P. W. Furlow et al., “Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease,” Journal of Neuroscience, vol. 27, no. 4, pp. 796–807, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Grutzendler, K. Helmin, J. Tsai, and W.-B. Gan, “Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 1097, pp. 30–39, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. C. M. Kirkwood, J. Ciuchta, M. D. Ikonomovic et al., “Dendritic spine density, morphology, and fibrillar actin content surrounding amyloid-β plaques in a mouse model of amyloid-β deposition,” Journal of Neuropathology and Experimental Neurology, vol. 72, no. 8, pp. 791–800, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Le, L. Cruz, B. Urbanc et al., “Plaque-induced abnormalities in neurite geometry in transgenic models of Alzheimer disease: implications for neural system disruption,” Journal of Neuropathology and Experimental Neurology, vol. 60, no. 8, pp. 753–758, 2001. View at Google Scholar · View at Scopus
  55. A. Sandberg, L. M. Luheshi, S. Sollvander et al., “Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 35, pp. 15595–15600, 2010. View at Google Scholar
  56. A. Feria-Velasco, A. R. del Angel, and I. Gonzalez-Burgos, “Modification of dendritic development,” Progress in Brain Research, vol. 136, pp. 135–143, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. M. L. Kramer and W. J. Schulz-Schaeffer, “Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with lewy bodies,” Journal of Neuroscience, vol. 27, no. 6, pp. 1405–1410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. C. R. Overk and E. Masliah, “Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease,” Biochemical Pharmacology, vol. 88, no. 4, pp. 508–516, 2014. View at Google Scholar
  59. R. P. Murmu, W. Li, A. Holtmaat, and J.-Y. Li, “Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of huntington's disease,” Journal of Neuroscience, vol. 33, no. 32, pp. 12997–13009, 2013. View at Publisher · View at Google Scholar · View at Scopus